The synthesis of smooth lipopolysaccharide (LPS) in relation to mouse virulence and resistance to serum bactericidal activity in vitro and to rapid intravenous clearance in vivo was studied in Salmonella typhimurium by using a virulent [median lethal dose (LD5o) = 1021], smooth, and genetically marked strain, a uridinediphosphogalactose epimerase-deficient mutant of it which was, therefore, rough, and a derivative of the mutant made smooth again by acquisition of the galactose-positive genes of Escherichia coli. The mutant was of reduced virulence (LD50 -= 106) but the smooth derivative regained the virulence character typical of the parent. The nonsmooth phenotype also made the mutant, but not the smooth relatives (parent and derivative), susceptible to serum bactericidal activity and also to rapid intravenous clearance by phagocytosis by the liver. The mutant was similarly treated by germfree mice (expected to be relatively free of opsonizing antibodies). The clearance of the mutant could be impaired by prior intravenous inoculation of homologous bacteria or their LPS but was reversible by preopsonization of the second inoculum with nonimmune mouse serum, suggesting that the initial inoculum preempted the opsonizing antibodies. Independent evidence of clearance specificity was also provided in mixed inoculum experiments on impaired mice by the rapid clearance of an antigenically unrelated heptose-deficient mutant while maintaining the decelerated clearance of the epimerase mutant. The latter, however, was converted to accelerated clearance by the intravenous inoculation during the impaired state of anti-epimerase mutant immune mouse serum.
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In various Salmonella species, mutants lacking uridine diphosphate (UDP)-galactose-epimerase (and formerly termed M mutants) are found to be much less virulent than their smooth parent strains (28, 31) , presumably because they are rough, synthesizing lipopolysaccharide (LPS) of the chemotype termed Rc (Fig. 1) . The availability of an epimerase-deficient mutant, derived from a smooth, mouse-virulent Salmonella typhimurium strain, and of its smooth derivative obtained by infecting it with an Escherichia coli K-12 F'-gal+ plasmid (16) (17, 24) for details. Abbreviations: abe, abequose; Oac, 0-acetyl; man, mannose; rha, rhamnose; gal, galactose; glc, glucose; glcNac, N-acetyl glucosamine; KDO, 2-keto-3-deoxyoctonic acid; hep, heptose; n, number of repeating units of 0 side-chain.
tose-epimerase-deficient mutant gal-456, isolated from TV253, and the corrected, smooth derivative of the mutant designated gal-456 (F'-1-gal+) have been described elsewhere (16) . Strains gal-456 cys+ and gal-456 his+ were transductants obtained from gal-456 as described elsewhere and were nonlysogenic for phage P22 and were confirmed to retain the identical phage pattern of gal-456 (16) . Strain TV253 his+ was a his+ transductant obtained from the smooth parent strain, TV253, and it was also nonlysogenic for phage P22 and confirmed to retain the identical phage pattern of TV253 (16) . Strain SL1102 is a rough mutant, rfaE543, of a genetically marked S. typhimurium LT2 line (10) ; it synthesizes LPS lacking heptose and all sugars distal to it (Fig. 1) . Strain SL 102 is resistant to high concentrations of streptomycin. S. paratyphi B strain Lister (15) and S. enteritidis strain Br'203C (30) are both smooth but serum-sensitive.
Media. These were as described (16) . Nutrient agar was supplemented with streptomycin (1 mg/ml) where appropriate. Phosphate buffer (0.1 M, pH 7.4) was used as diluent.
LPS from UDP-galactose-4-epimerase-deficient mutant. Purified LPS was prepared by the method of R. G. Wilkinson by hot phenol extraction and Mg2+ precipitation (25) from an LT2 epimerase-deficient mutant, number G-30 (27) . A solution of 20 mg/ml, made by heating lyophilized LPS in 0.85% NaCl at 100 C for 5 to 10 min, was diluted in buffer before use. Mice. Female mice (18 to 22g) of the conventional (specific-pathogen-free) and germ-free lines of an inbred strain, CF no. 1, were purchased from Carworth Inc., New City, N.Y. Conventional mice were used in all experiments unless otherwise stated. The germ-free mice were used immediately upon arrival.
Virulence titrations. Mice were inoculated intraperitoneally with 0.2-ml volumes of serial decimal dilutions in buffer of overnight broth cultures (15) .
Mortality was recorded daily for 28 days, and the median lethal dose (LD5) dose was calculated (26) .
Sera. Pooled serum from nonimmunized (normal) conventional or from germ-free mice was collected as described (15) . Anti-S. typhimurium and anti-S. enteritidis immune mouse sera (from mice vaccinated with heat-killed smooth bacteria) were obtained from E. P. Ornellas of this department. Anti-gal-456 immune mouse serum was from mice inoculated intraperitoneally at weekly intervals with 1.8 X 105, 1.3 X 106, and 6.5 X 106 live bacteria of strain gal-456 and bled two weeks after the final inoculation. Fetal calf serum was purchased from Hyland Laboratories, Los Angeles, Calif.
Adsorption of fetal calf serum. A 400-ml amount of gal-456 culture [grown for 18 hr in Brain Heart Infusion broth (Difco) and having a viable count of 1.4 X 109/ml] was centrifuged, washed twice in saline, heated at 70 C for 2 hr, and washed three times, and the cell pellet was resuspended in 0.5 ml of saline. Twenty milliliters of serum was mixed with one-third of the cell suspension. After 6 hr at 4 C the, serum was freed of cells by centrifugation, and the adsorption was repeated twice more.
Titration of mouse serum by the bactericidal test.
Mouse serum titrations were performed as described (30) . Bacteria (grown in Difco Brain Heart Infusion broth) were sensitized by mixingabout 2,500 cells in 0.1 ml of buffer with 0.4 ml of a dilution of mouse serum (presumed antibody source) and incubating for 30 min at 37 C and then for 2 hr at 4 C. To 0.1 ml of the suspension of sensitized bacteria, 0.4 ml of undiluted fetal calf serum (complement source) was then added. At 1 and 2 hr at 37 C, 0.1-ml samples were plated on nutrient agar ( Difco). Three controls were always included:
in the complement control, mouse serum was replaced by buffer; in the buffer control, both the mouse and fetal calf sera were replaced by buffer; in the mouse serum control, calf serum was replaced by buffer. zero-time counts were made by plating from the mouse serum control tube. The number of viable bacteria in the buffer controls at the end of 2 hr was always about the same as at zero time.
Measurement of clearance of intravenously inoculated viable bacteria from the blood stream. A 0.2-ml amount of a bacterial suspension was injected into the tail vein of a mouse and then, at intervals, 0.05 ml of blood was obtained from the retro-orbital venous plexus, diluted, and plated on appropriate agar media for the enumeration of recovery of viable bacteria (15) . As a precaution against intravascular clotting (1) heparin (100 units) was inoculated intravenously 5 to 10 min before inoculation of test bacteria. In experiments in which viable bacteria or LPS was inoculated, to effect immunological impairment, the heparin was inoculated together with the material used for impairment. When the inoculum was a mixture of 2 to 3 different strains, viable counts of the component strains were made by simultaneous platings on appropriate selective or indicator media. The clearance rate or "phagocytic index," K, was determined by calculating the slope of the regression line of viable count against time. The slope and its standard error (SE) and the intercept were calculated by the method of least squares on an IBM360 model 50 computer. In some experiments, the mice were killed (5 min after inoculation of bacteria), and viable counts were made from dilutions of homogenates of liver and of spleen (15) .
Opsonization in vitro. One milliliter of undiluted serum and an equal volume of broth culture were mixed and held at 4 C for 20 min, and then 0.2 ml of the unwashed mixture of bacteria and serum was inoculated intravenously into mice (15) . Preopsonization of gal-456 cys+ with anti-gal456 immune mouse serum was done with 1:1,000 dilution of the serum (since under these conditions its agglutinating titer, observed microscopically, was 1:512), and, after 60 min, the bacteria were freed of unabsorbed antibodies by membrane filtration and rinsing with ice cold buffer and were then kept on ice until inoculated.
RESULTS
Mouse virulence. Table 1 shows that the smooth, parental gal+ strain TV253 was highly virulent for the mouse by the intraperitoneal route. The LD50 calculated by the method of Reed and Muench (26) was 90 bacteria with a mean death time of 10 days. The smooth his+ transductional derivative of TV253 also retained its virulence (LD50 = < 11 bacteria). A point that is worth making regarding the mouse virulence of highly mouse-virulent strains was the observation of "interference," a phenomenon somewhat analogous to that described in Bordetella pertussis infections (6) (7) (8) (9) (26) .
d No mortality was observed in additional groups of five mice inoculated with smaller doses, i.e., 9 .1 x 102, 9.1 X 10', and 9.1 X 10°bacteria. correct if the prozone phenomenon (20) was operative since dilutions of mouse serum were not tested against smooth strains ( Table 2) .
Rates of clearance of bacteria inoculated intravenously. As strain gal-456 synthesizes LPS of chemotype Rc (Fig. 1) , owing to its deficiency of UDP-galactose-epimerase (16) , it was expected that it, but not its smooth parent TV253, would be rapidly cleared from the bloodstream after intravenous inoculation. Therefore, the clearance rates of a his+ transductional derivative of TV253 (= TV253 his+) and of a cys+ transductional derivative of gal-456 ( = gal-456 cys+) were measured in two separate groups of conventional mice (Fig. 2) . As expected, the smooth, virulent transductional derivative of the parent strain TV253 was not detectably cleared (K = 0.003 4 0.007), whereas the nonvirulent epimerasedeficient gal-456 cys+ was very rapidly cleared (K = 0.316 i 0.031).
Clearance of the epimerase-deficient mutant and its cured derivative, inoculated together into mice. It was next of interest to determine whether correcting the epimerase defect of gal-456 by the F'-1-gal+ plasmid from E. coli would prevent its rapid removal from the bloodstream. Three mice were injected intravenously with a mixture of gal-456 and gal-456 (F'-1-gal+) so that each mouse received about 5 x 104 bacteria of each serum plus various dilutions of homologous mouse immune serum, i.e., anti-4,5,12 serum, from mice vaccinated with heat-killed smooth S. typhimurium cells (Table 3) . In samples taken after 1 hr both strains appeared somewhat sensitive, in that all dilutions (1:100, 1:1,000, and 1:5,000) of immune serum caused some killing (survivals 20 to 50% 
strain. After a number of blood samples had been obtained, they were killed at 5 min and spleen and liver counts were made (Fig. 3) . As expected the cured F' derivative was not rapidly removed, whereas gal-456 was. The rapid disappearance of viable gal-456 cells from the circulation evidently resulted in large part from their retention within the liver, for an average of 36%ho (range 25 to 44%) of the viable count of the inoculum was found in this organ (Fig. 3) . By contrast, only 3.2% (range 2.5 to 4%c) of the inoculum of gal-456 (F'-1-gal+) was recovered from the liver. The number of bacteria recovered from the spleen was small for both strains, i.e., 0.4% of inoculum for gal-456 and 0.8 % for gal-456 (F'-1-gal+) .
Clearance of gal-456 and gal-456 (F'-l-gal+) inoculated together into germ-free mice. As opsonizing antibodies accelerate the clearance of bacteria from the bloodstream (1, 12), it seemed that rapid clearance of gal-456 cells from the bloodstream of conventional mice might result from the presence in their sera of antibodies active on the type Rc (epimerase-deficient) LPS of gal-456 cells. It was surmised that the sera of germ-free mice might lack such antibodies because of lack of antigenic stimulation by bacteria. Mixed inoculum experiments were therefore made in germ-free mice (Fig. 4) . In all four mice, gal-456 was cleared about as rapidly as in conventional mice, whereas the cured derivative was not detectably removed. The recovery of gal-456 cells from the livers of the germ-free mice (48, 43, 37, and 40 of inoculum, with a mean of 42%) was about the same as in the case of conventional mice, as also were the recoveries of gal-456 from the spleen and of the cells of the cured derivative from the liver and spleen. Thus it seems that the germ-free mice either possess adequate amounts of opsonizing antibodies active on gal-456 or rapid clearance of "rough" bacteria of this sort is not dependent on possession of opsonizing antibodies.
Impairment of clearance of epimerase-deficient cells by prior inoculation of homologous viable bacteria and its partial reversal by preopsonization. If the very rapid clearance of gal-456 cys' (Fig. 2) was due to the presence of opsonizing antibodies in the serum of conventional mice, then prior intravenous inoculation of an excess of the homologous viable bacteria should reduce the rate of clearance of a subsequent intravenous inoculum (12, 13) , and preopsonization (in vitro) of the second inoculum with conventional mouse serum should restore clearance in such impaired mice (13) . To distinguish the first and second viable inocula, transductional derivatives of gal-456 were used. The first inoculum consisted of 5 that inocula of 5 X 109 to 1010 cells did not cause substantial impairment of clearance of the second inoculum. The first inoculum would by itself have killed the mice in a few hours, but it seemed unlikely that its toxic effects would influence the outcome of the clearance experiments since these were completed within 8 min after the first inoculum was given.) Five nminutes after the first inoculum, three mice were injected intravenously with nonopsonized gal-456 cys+ and three with gal-456 cys+ preopsonized by incubation in normal conventional mouse serum. In the latter case, the mice were inoculated with the bacterial-serum mixture. The results (Fig. 5) showed that, as expected, the prior inoculation (Fig 1) . A preliminary experiment (Fig. 2) showed that SL1102 cells Acceleration of clearance of epimerase-deficient bacteria in impaired mice by intravenous inoculation of immune mouse serum. Because of the failure of preopsonization in dilute immune serum to reverse impairment (Fig. 6) , the effect of intravenous inoculation of undiluted immune serum during clearance was next tested; this procedure has been shown to accelerate the rate of clearance of cells that were initially poorly phagocytized (3). Each of three mice was inoculated intravenously with 0.6 mg of LPS of type Rc and 5 min later with a mixture of gal-456 and SL1102 cells. Blood samples were taken at intervals. At 4 min, 0.1 ml of undiluted anti-gal-456 immune mouse serum was injected intravenously and further blood samples were taken up to 8 min. It was found in all three mice (Fig. 7) (Fig. 3 and 4) . 
DISCUSSION
The strains used for mouse experiments, i.e., the mouse-virulent parent strain TV253, its UDP-galactose-epimerase-deficient mutant gal-456, and the "cured" derivative of the latter, were isogenic except for their gal genes and for the his C or cys G genes, in the case of the transductional derivatives of TV253 and gal456. But, as these derivatives had the same virulence (Table 1) and phage patterns (16) as their his cys-parents, these marker characters may be disregarded in considering the behavior of the strains after inoculation into mice. As was expected, the almost complete lack of epimerase in gal-456, with consequent inability to form smooth LPS, resulted in a very great reduction in virulence (LD50 _ 106, compared with LD50 _ 100 for the parent strain). But, on conversion to smoothness, the mutant regained the virulence character typical of the parent strain. The decreased virulence associated with inability to synthesize smooth LPS corresponds to that reported for epimerase-deficient mutants of various Salmonella species by Saito (28) and by Ushiba and Kitasato (31) , of E. coli 0111:B4 by Medearis et al. (18) , and for mutants of S. typhimurium strains LT2 and 395MS with various other defects in LPS synthesis (5, 22) . The epimerase-deficient mutant was not totally nonvirulent since some mice died from inocula of ca. 104 to 105 cells, and evidently died as a result of multiplication of the mutant cells themselves rather than from growth of a galactose-positive (and therefore virulent) revertant since only galactose-negative bacteria were recovered from post-mortem cultures. It is not known whether the residual virulence of gal-456 was related to the leakiness of its enzyme defect (16) . This point could be determined by testing the virulence of mutants with deletions of the galactose genes derived from a mouse-virulent strain.
The nonsmooth phenotype resulting from the epimerase defect of gal-456 made it susceptible to rapid removal from the circulation (phagocytic index K = 0.316 i-0.031; Fig. 2 ), whereas the smooth parent strain (K = 0.003 0.007; Fig.  2 ) and the cured derivative (Fig. 3) (Fig. 3) . Other investigations, including those of Nakano and Saito (21) and Hofman et al. (11) have shown that nonsmooth Salmonella injected intravenously into normal mice or newborn colostrum-deprived piglets are very rapidly removed from the circulation (and are correspondingly susceptible to rapid uptake by phagocytosis if injected intraperitoneally), whereas most smooth Salmonella strains are cleared only slowly (11, 15, 21 ; but see reference 15 for an instance of an apparently smooth Salmonella strain which was rapidly cleared from the circulation of nonimmunized mice). Medearis and his colleagues (18) observed similar susceptibility to phagocytosis of cells of an epimerase-deficient mutant of E. coli 0111 :B4 inoculated intraperitoneally into normal mice, and Dlabac (4; personal communication) found that cells of an epimerase-deficient mutant of S. typhimurium LT2 were efficiently removed during perfusion of the livers of normal rats or newborn piglets. In both of these instances, bacteria grown in the presence of galactose were less rapidly removed, as a consequence of the restoration of smooth phenotype by utilization of exogenous galactose for LPS synthesis. In these experiments, counts of viable bacteria in the livers and spleens of mice killed 5 min after inoculation showed that a high proportion (25 to 44%G) of the inoculated gal-456 cells were recoverable from the liver but only 0.3 to 0.5% from the spleens. If one assumes that the liver of a 20-g mouse weighs about 1.35 g and its spleen about 0.15 g (2), it appears that on an equal-weight basis liver retains about nine times as many gal-456 viable bacteria as spleen. Similar observations have been made in respect of clearance of a rough strain of S. typhi (3), but the liver was only twice as efficient as spleen in uptake of heat-killed S. enteritidis (2) In the group of three mice pretreated with live bacteria of type Rc, the clearance rate of the test inoculum of gal-456 cys+ cells was 0.042 i 0.021. In a second group given the same pretreatment, the test inoculum of gal-456 cys+ had been opsonized by incubation for 20 min in undiluted serum of conventional mice. This treatment resulted in clearance at a significantly more rapid rate (K = 0.118 :1 0.009; Fig. 5 ) but did not restore the rate observed in nonimpaired mice (K = 0.316 i 0.031; Fig. 2 ). It was suspected that the incomplete restoration of normal rapid clearance might reflect low affinity of the postulated opsonizing antibody in the serum of nonimmunized mice, resulting in dissociation when the serum-bacteria mixture was diluted by inoculation into the mice. It was supposed that opsonizing antibodies in the serum of specifically immunized mice would have high affinity and, therefore, not dissociate on inoculation. However, in an experiment (Fig. 6 ) with mice pretreated with 0.5 mg of LPS, an inoculum of gal-456 (genetically tagged) cells opsonized in immune mouse serum was cleared no more rapidly than the nonopsonized gal-456 component of the mixed inoculum (K = 0.093 ± 0.009 for the cys+ opsonized cells and 0.088 ± 0.003 for the nonopsonized his+ component). It is not known why opsonization in immune serum failed to cause more rapid clearance; the immune serum was used at a dilution of 1:1,000 (to avoid 0 agglutination) and perhaps the concentration of antibodies or of adjuvant factors, e.g., complement components, in the diluted serum was insufficient for effective opsonization.
In mice which 5 min earlier had received 0.6 mg of type Rc LPS, the gal-456 component of a mixed inoculum was, as expected, cleared more slowly than the heptose-negative SLi102 component (Fig. 7) ; injection of 0.1 ml of undiluted immune (anti-gal-456) mouse serum 4 min after the test inoculum resulted in acceleration of clearance of gal-456 (K value for first 3 min = 0.068 i 0.021; for last 4 min = 0.134 i 0.034), whereas the clearance of the heptose-negative component became less rapid (K before injection of immune serum = 0.179 i 0.029; after immune serum = 0.077 i 0.062). The rates of clearance generally decline after the first 90% of the bacteria have been removed so that plots of log viable count against time if taken beyond this point are concave upwards (see Fig. 7 , and references 1-3, 22), and it is therefore believed that the acceleration of clearance of gal-456 after injection of immune serum was indeed caused by the opsonizing effect of the antibody in the serum.
All of the observations are compatible with the hypothesis that the rapid clearance of gal-456 cells, largely by their uptake by the liver, results from the opsonizing effect of antibodies present in the serum of both conventional and germ-free mice. Furthermore, sera from both conventional and germ-free mice when supplemented with absorbed fetal calf serum proved bactericidal to gal-456 cells. (Table 2 ). The killing of gal-456 by normal mouse serum in the presence of specifically absorbed fetal calf serum (but by neither serum alone) was attributed to the presence of bactericidal antibodies against Rc LPS in the serum of both conventional and of germ-free mice, together with the sensitivity of gal-456 to the bactericidal action of homologous anti-LPS antibody plus complement, a property typical of nonsmooth mutants. Similarly, the killing of
